Page last updated: 2024-08-17

levodopa and Hallucinations

levodopa has been researched along with Hallucinations in 122 studies

Research

Studies (122)

Timeframe	Studies, this research(%)	All Research%
pre-1990	29 (23.77)	18.7374
1990's	20 (16.39)	18.2507
2000's	45 (36.89)	29.6817
2010's	20 (16.39)	24.3611
2020's	8 (6.56)	2.80

Authors

Authors	Studies
Bai, Y; Gu, R; Jiang, X; Jiang, Y; Pan, Y; Shen, B; Wang, Y; Yan, J; Zhang, L; Zhong, M; Zhu, J; Zhu, S	1
Horiguchi, S; Ito, S; Takahashi, M; Tsuji, Y	1
Barbara, JM; Pace, A	1
Espiritu, AI; Jamora, RDG; Pajo, AT	1
Aktürk, T; Güntekin, B; Hanoğlu, L; Hanoğlu, T; Yulug, B	1
Fujita, H; Haruyama, Y; Hatano, T; Hattori, N; Hirano, S; Hirata, K; Kadowaki, T; Kaji, Y; Kobashi, G; Kuwabara, S; Miyamoto, M; Okuma, Y; Sakakibara, R; Shimo, Y; Suzuki, K; Uchiyama, T; Yamamoto, T	1
Abbasi, MH; Esmaeili, S; Habibi, SA; Shahidi, GA	1
Kimpara, T; Takeda, A	1
Lee, AJ; Poon, LH; Vuong, M; Zuzuarregui, JR	1
Abe, T; Maruyama, H	1
Brock, P; Fisher, JM; Hand, A; Walker, RW	1
Asano, AGC; Asano, NMJ; Damasceno Dos Santos, EU; de Souza, PRE; Duarte, EBC; Maia, MMD; Miranda, LMR	1
Archie, A; Persoons, P; Vandenbulcke, M	1
Barrou, Z; Boddaert, J; Dieudonné, B; Faucounau, V; Greffard, S; Habert, MO; Verny, M	1
Hayashi, R; Kohsaka, M; Oeda, T; Sawada, H; Sudoh, S; Sugiyama, H; Tomita, S; Umemura, A; Yamamoto, K	1
Bonuccelli, U; Ceravolo, R; Giuntini, M; Kiferle, L; Linsalata, G; Puccini, G; Volterrani, D	1
Hattori, N	1
Fukuda, K	1
Espay, AJ; Espay, KJ; Fasano, A; Krikorian, R; Ricciardi, L	1
Auerbach, S; Cronin-Golomb, A; Durso, R; Harris, E; McNamara, P; Stavitsky, K	1
Brandabur, M; Goetz, CG; Goldman, JG; Sanfilippo, M; Stebbins, GT	1
Hashiguchi, K; Kawaguchi, M; Kishimoto, J; Miyagi, Y; Morioka, T; Murakami, N; Sakae, N; Samura, K; Sasaki, T; Yamasaki, R; Yoshida, F	1
Baker, WL; Coleman, CI; Patel, AA; Reinhart, K; Talati, R	1
Devos, D	1
Compta, Y; Ezquerra, M; Martí, MJ; Rey, MJ	1
Diederich, NJ; Fénelon, G; Goetz, CG; Stebbins, G	1
Chaná, P	1
Bugalho, P; da Silva, JA; Neto, B	1
Hama, T; Hara, T; Hirayama, M; Ito, M; Nakamura, T; Niimi, Y; Ohno, K; Sobue, G; Uchida, K; Watanabe, H	1
Matsukawa, N; Oka, Y; Okita, K; Umemura, A; Yamada, K	1
Bachoud-Lévi, AC; Cleret de Langavant, L; Fénelon, G; Soulas, T; Trinkler, I	1
Agarwal, P; Alcalay, R; Black, KJ; Chou, KL; Cote, L; Dayalu, P; Frank, S; Friedman, JH; Hartlein, J; Hauser, RA; Lang, AE; Marsh, L; Marshall, F; Moskowitz, C; Ravina, B; Riley, D; Sanchez-Ramos, J; Simon, DK; Simuni, T; Sutton, J; Tuite, P; Weintraub, D; Zesiewicz, T	1
Inoue, M; Inoue, Y; Kishimoto, T; Kiuchi, K; Kosaka, J; Morikawa, M; Norimoto, K	1
Brotchie, JM; Darr, T; Fox, SH; Hazrati, LN; Huot, P; Johnston, TH; Pires, D; Visanji, NP	1
Chouinard, S; Gagnon, JF; Latreille, V; Montplaisir, J; Panniset, M; Postuma, RB; Romenets, SR	1
Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M	1
Levenson, D	1
Schölzel-Dorenbos, CJ	1
Sulkava, R	1
Borra, S; Hauser, RA; Zesiewicz, TA	1
Hagenah, J; Kömpf, D; Moser, A	1
Kodama, R; Kondo, T; Miwa, H; Morita, S	1
Evatt, ML; Jewart, RD; Jou, HC; Juncos, JL; Potter, LS; Roberts, VJ; Wood, CD; Yeung, PP	1
Foster, HD; Hoffer, A	1
Kuzuhara, S; Naito, Y	1
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F	1
Bang, OY; Joo, US; Lee, PH; Seo, CH	1
Giladi, N; Korczyn, AD; Merims, D; Peretz, C; Shabtai, H; Weizman, N	1
Argyriou, AA; Ellul, J; Papapetropoulos, S	1
Inzelberg, R; Paleacu, D; Schechtman, E	1
Curgian, L; Goetz, CG; Leurgans, S; Wuu, J	1
Kitagawa, M; Tashiro, K	1
Fénelon, G; Goetz, CG; Karenberg, A	1
Le Rhun, E; Lebert, F	1
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Tamura, A; Udaka, F	1
Eberly, SW; Goetz, CG; Oakes, D; Schwid, SR; Shoulson, I	1
Albani, G; Bonanni, L; Bulla, D; Mauro, A; Onofrj, M; Thomas, A	1
Bernardi, S; Meco, G	1
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Pires, D; Visanji, NP; Voon, V	1
Waldvogel, D	1
Erginöz, E; Ertan, S; Ertan, T; Kiziltan, G; Ozekmekçi, S	1
Holton, J; Kempster, PA; Lees, AJ; Revesz, T; Selikhova, M; Williams, DR	1
Bargalló, N; Giménez, M; Junqué, C; Martí, MJ; Ramírez-Ruiz, B; Tolosa, E; Valldeoriola, F	1
Biglan, KM; Holloway, RG; McDermott, MP; Richard, IH	1
Aydemir, T; Cetin, S; Erol, C; Hanoglu, L; Meral, H; Ozben, S; Ozer, F; Ozkayran, T; Ozturk, O; Yilsen, M	1
Adena, MA; Halliday, GM; Hely, MA; Morris, JG; Reid, WG	1
Burns, R	1
Ballard, P; Langston, JW	1
Coignet, A; de Recondo, J; Rondot, P; Ziegler, M	1
Baum, R; Glantz, R; Klawans, HL; Nausieda, PA; Weber, S	1
Klawans, HL; Nausieda, PA; Tanner, CM	1
Goetz, CG; Klawans, HL; Koller, WC; Nausieda, PA; Perlik, S; Weiner, WJ	1
Hikiji, A; Ideshita, H; Morita, H; Sasaki, T; Yoshinaga, J	1
Lees, AJ; Shaw, KM; Stern, GM	1
Alessandria, A; Bonifati, V; Giustini, P; Meco, G	1
Winn, P	1
Camicioli, R; Joseph, CL; McWhorter, K; Siple, J	1
Standaert, DG; Stern, MB	1
Lauterbach, EC	1
Comella, CL; Ristanovic, RK; Tanner, CM	1
Helscher, RJ; Pinter, MM	1
Lang, AE; Riley, DE	1
Friedberg, G; Melamed, E; Weizman, A; Zoldan, J	1
Dike, GL	1
Cabrera-Valdivia, F; Fernández-Lliria, A; Gasalla, T; Jiménez-Jiménez, FJ; Ortí-Pareja, M; Tallón-Barranco, A	1
Blasucci, LM; Carvey, PM; Goetz, CG; Ling, ZD; Nora, MV; Pappert, EJ; Stebbins, GT	1
Jaskowski, P; Kömpf, D; Moser, A; Siebecker, F; Vieregge, P	1
Goetz, CG; Stebbins, GT; Tanner, CM; Vogel, C	1
Friedman, JH	1
Kobayashi, S; Oguro, H; Okada, K; Suyama, N; Yamaguchi, S	1
Ghaemi, M; Rudolf, J; Schmülling, S	1
Aitchison, KJ; Arranz, MJ; Forsyth, J; Graham, JM; Grünewald, RA; Li, T; Makoff, AJ; Shaikh, S	1
Yamamoto, T	1
Goetz, CG; Leurgans, S; Pappert, EJ; Raman, R; Stemer, AB	1
Brenninkmeijer, JH; Freijzer, PL	1
Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F	1
Bailbé, M; Dumas, P; Gil, R; Karolewicz, S; Neau, JP	1
Steur, EN	1
Klawans, HL; Lupton, MD; Moskovitz, C; Sharf, B	1
Postma, JU; Van Tilburg, W	1
Lance, JW; Mackenzie, RA	1
Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E	1
Klawans, HL; Moses, H; Moskovitz, C	1
Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM	1
Moore, DP	1
Askenazi, JJ; Rabey, JM; Streifler, M; Vardi, J	1
Marsden, CD; Quinn, NP; Steiger, MJ; Toone, B	1
Baratta, P; Falini, A; Ferrante, C; Motti, E; Mulazzi, D; Pezzoli, G; Pizzuti, A; Silani, V; Vegeto, A; Zecchinelli, A	1
Graber, B; Hofman, R; Kang, J; Pfeiffer, RF; Wilson, J	1
Aarli, JA; Gilhus, NE	1
Banerjee, AK; Falkai, PG; Savidge, M	1
Smith, RG; Wilson, JA	1
Golden, WE; Lavender, RC; Metzer, WS	1
Dichgans, J; Scholz, E	1
Nutt, JG	1
Klawans, HL	1
Hara, K; Iijima, S; Kameyama, M; Nakamura, S	1
Bieliauskas, L; Glantz, RH; Paleologos, N	1
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM	1
Il'inskiĭ, IA; Safronov, VA; Vasin, NIa	1
Baker, AB; Loewenson, RB; Martin, WE; Resch, JA	1

Reviews

15 review(s) available for levodopa and Hallucinations

Article	Year
Efficacy and safety of extended-release amantadine in levodopa-induced dyskinesias: a meta-analysis. Neurodegenerative disease management, 2019, Volume: 9, Issue:4 Topics: Accidental Falls; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Bias; Constipation; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome; Xerostomia	2019
Amantadine Associated Myoclonus: Case Report and Review of the Literature. Journal of pharmacy practice, 2021, Volume: 34, Issue:5 Topics: Aged, 80 and over; Amantadine; Hallucinations; Humans; Levodopa; Male; Myoclonus; Parkinson Disease	2021
[Programs for continuing medical education: a session: 4. The pathogenesis and update for the treatments of Parkinson's disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2014, Mar-10, Volume: 103, Issue:3 Topics: Benserazide; Benzothiazoles; Catechols; Circadian Rhythm; Dementia; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Dyskinesias; Education, Medical, Continuing; Hallucinations; Humans; Levodopa; Nitriles; Parkinson Disease; Practice Guidelines as Topic; Pramipexole; Reference Standards; Referral and Consultation	2014
Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. International journal of clinical practice, 2009, Volume: 63, Issue:4 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome	2009
Hallucinations in Parkinson disease. Nature reviews. Neurology, 2009, Volume: 5, Issue:6 Topics: Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition Disorders; Hallucinations; Humans; Illusions; Levodopa; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Sleep Wake Disorders	2009
[Advances in the medical treatment of Parkinson's disease]. Parkinsonism & related disorders, 2009, Volume: 15 Suppl 3 Topics: Antiparasitic Agents; Disorders of Excessive Somnolence; Dopamine Agonists; Hallucinations; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease	2009
Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies. Advances in neurology, 2003, Volume: 91 Topics: Brain; Cognition Disorders; Diagnosis, Differential; Disease Progression; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Parkinson Disease	2003
[Drug induced dementia--anti-parkinsonian drugs]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl Topics: Antiparkinson Agents; Basal Ganglia; Cerebral Cortex; Cholinergic Antagonists; Dementia; Hallucinations; Humans; Levodopa; Neurotransmitter Agents	2004
[Treatment of dementia with Lewy bodies]. Revue neurologique, 2006, Volume: 162, Issue:1 Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy	2006
Visual hallucinations in Parkinson's disease: clues to separate origins. Journal of the neurological sciences, 2006, Oct-25, Volume: 248, Issue:1-2 Topics: Antiparkinson Agents; Evoked Potentials, Visual; Hallucinations; Humans; Levodopa; Longitudinal Studies; Models, Biological; Parkinson Disease; REM Sleep Behavior Disorder	2006
[Medical treatment of Parkinson's disease]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:1 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Cholinergic Antagonists; Controlled Clinical Trials as Topic; Dementia; Depression; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Dyskinesias; Hallucinations; Humans; Levodopa; Middle Aged; Multicenter Studies as Topic; Pain; Parkinson Disease; Quality of Life; Therapeutic Equivalency; Time Factors	2007
Update on the management of Parkinson's disease. The Medical clinics of North America, 1993, Volume: 77, Issue:1 Topics: Depression; Diagnosis, Differential; Dopamine Agents; Hallucinations; Humans; Levodopa; Parkinson Disease; Selegiline	1993
[Psychiatric manifestations induced by dopamine precursors or antagonists]. Annales medico-psychologiques, 1979, Volume: 137, Issue:9 Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride	1979
Visual hallucinations in the elderly associated with the use of levodopa. Postgraduate medical journal, 1989, Volume: 65, Issue:764 Topics: Aged; Aged, 80 and over; Female; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Vision, Ocular	1989
Psychiatric side effects during the treatment of Parkinson's disease. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: Dreams; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa; Mental Disorders; Paranoid Disorders; Parkinson Disease; Serotonin; Severity of Illness Index; Sleep Wake Disorders	1988

Trials

8 trial(s) available for levodopa and Hallucinations

Article	Year
Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Movement disorders : official journal of the Movement Disorder Society, 2008, Nov-15, Volume: 23, Issue:15 Topics: Aged; Dopamine Agonists; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Mental Disorders; Movement Disorders	2008
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Brief Psychiatric Rating Scale; Delusions; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate	2004
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology, 2007, Jul-10, Volume: 69, Issue:2 Topics: Adult; Age Distribution; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cohort Studies; Comorbidity; Disorders of Excessive Somnolence; Double-Blind Method; Edema; Female; Hallucinations; Heart Diseases; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Risk Factors; Sex Distribution	2007
Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease. Advances in neurology, 1996, Volume: 69 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Delusions; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Ondansetron; Parkinson Disease; Serotonin Antagonists	1996
Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics, 2000, Volume: 10, Issue:1 Topics: Alleles; Antiparkinson Agents; Dopamine Agonists; Female; Gene Frequency; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Hallucinations; Haplotypes; Humans; Levodopa; Male; Middle Aged; Odds Ratio; Parkinson Disease; Polymorphism, Genetic; Receptors, Dopamine D2; Receptors, Dopamine D3	2000
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease	2002
An evaluation of bromocriptine in the treatment of Parkinson's disease. Clinical and experimental neurology, 1978, Volume: 15 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease	1978
A controlled study comparing trihexyphenidyl hydrochloride plus levodopa with placebo plus levodopa in patients with Parkinson's disease. Neurology, 1974, Volume: 24, Issue:10 Topics: Affective Symptoms; Aged; Anxiety; Clinical Trials as Topic; Confusion; Drug Evaluation; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Placebos; Sleep Wake Disorders; Time Factors; Trihexyphenidyl; Vomiting	1974

Other Studies

99 other study(ies) available for levodopa and Hallucinations

Article	Year
Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson's Disease: A Cross-Sectional Study. Behavioural neurology, 2022, Volume: 2022 Topics: Cross-Sectional Studies; Female; Hallucinations; Homocysteine; Humans; Levodopa; Male; Parkinson Disease	2022
Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson's disease: Final report of a post-marketing surveillance study in Japan. Journal of the neurological sciences, 2022, 12-15, Volume: 443 Topics: Adult; Aged; Drug-Related Side Effects and Adverse Reactions; Female; Hallucinations; Humans; Japan; Levodopa; Male; Parkinson Disease; Product Surveillance, Postmarketing; Prospective Studies	2022
Amantadine toxicity causing visual hallucinations. Practical neurology, 2023, Volume: 23, Issue:5 Topics: Amantadine; Antiparkinson Agents; Female; Hallucinations; Humans; Levodopa; Multiple Sclerosis	2023
The therapeutic role of repetitive transcranial magnetic stimulation (rTMS) in parkinsonian visual hallucinations: Electrophysiological correlates. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2019, Volume: 69 Topics: Aged, 80 and over; Antiparkinson Agents; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Pramipexole; Transcranial Magnetic Stimulation	2019
Determinants of Low Body Mass Index in Patients with Parkinson's Disease: A Multicenter Case-Control Study. Journal of Parkinson's disease, 2020, Volume: 10, Issue:1 Topics: Aged; Body Mass Index; Case-Control Studies; Constipation; Deglutition Disorders; Dopamine Agents; Dyskinesias; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index	2020
Dilemma in Parkinson's Treatment; Levodopa Monotherapy May be the Best Choice. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 79 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Depression; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Pramipexole; Psychotic Disorders; Quality of Life	2020
[Parkinson's Disease in the Oldest-Old]. Brain and nerve = Shinkei kenkyu no shinpo, 2020, Volume: 72, Issue:12 Topics: Age of Onset; Aged; Aged, 80 and over; Hallucinations; Humans; Levodopa; Parkinson Disease; Prevalence	2020
[Effects of switching from dopamine agonists to zonisamide on psychiatric and motor symptoms in patients with Parkinson's disease]. Rinsho shinkeigaku = Clinical neurology, 2021, Jul-30, Volume: 61, Issue:7 Topics: Dopamine Agonists; Drug Substitution; Hallucinations; Humans; Levodopa; Parkinson Disease; Zonisamide	2021
Highlighting the goals for Parkinson's care: commentary on NICE Guidelines for Parkinson's in Adults (NG71). Age and ageing, 2019, 05-01, Volume: 48, Issue:3 Topics: Antiparkinson Agents; Clozapine; Hallucinations; Humans; Levodopa; Parkinson Disease; Patient Care Team; Patient Education as Topic; Practice Guidelines as Topic	2019
Pharmacogenetic Profile and the Occurrence of Visual Hallucinations in Patients With Sporadic Parkinson's Disease. Journal of clinical pharmacology, 2019, Volume: 59, Issue:7 Topics: Aged; Alleles; Antiparkinson Agents; Female; Genetic Predisposition to Disease; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pharmacogenetics; Polymorphism, Single Nucleotide	2019
[The use of clozapine and levodopa for the treatment of persistent visual hallucinations and parkinsonism in Lewy body dementia]. Tijdschrift voor psychiatrie, 2013, Volume: 55, Issue:4 Topics: Aged; Antipsychotic Agents; Brain; Clozapine; Comorbidity; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Parkinson Disease; Treatment Outcome	2013
Utility of 123I-FP-CIT SPECT for dementia diagnoses and therapeutic strategies in elderly patients. The journal of nutrition, health & aging, 2014, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dopamine Plasma Membrane Transport Proteins; Female; Geriatric Assessment; Hallucinations; Humans; Levodopa; Lewy Body Disease; Male; Retrospective Studies; Tomography, Emission-Computed, Single-Photon	2014
Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study. PloS one, 2014, Volume: 9, Issue:1 Topics: Amantadine; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Delusions; Dopamine Agents; Hallucinations; Humans; Illusions; Levodopa; Logistic Models; Multivariate Analysis; Parkinson Disease; Psychotic Disorders; Risk Factors; Selegiline; Surveys and Questionnaires	2014
Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT study. Parkinsonism & related disorders, 2014, Volume: 20, Issue:7 Topics: Aged; Caudate Nucleus; Denervation; Dopamine; Dopaminergic Neurons; Female; Hallucinations; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tropanes	2014
Integrated theory to unify status among schizophrenia and manic depressive illness. Medical hypotheses, 2015, Volume: 85, Issue:4 Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biopterins; Bipolar Disorder; Blood-Brain Barrier; Depression; Depression, Postpartum; Dopamine; Female; Hallucinations; Humans; Kynurenic Acid; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurotransmitter Agents; Paranoid Disorders; Premenstrual Syndrome; Schizophrenia; Seasonal Affective Disorder; Serotonin; Serotonin Syndrome; Tyrosine	2015
Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease. Parkinsonism & related disorders, 2016, Volume: 28 Topics: Antiparkinson Agents; Antipsychotic Agents; Brain Diseases, Metabolic; Capgras Syndrome; Clozapine; Dopamine; Hallucinations; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Psychoses, Substance-Induced	2016
Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2008, Volume: 21, Issue:3 Topics: Aged; Antiparkinson Agents; Brain; Cognition Disorders; Disorders of Excessive Somnolence; Dreams; Female; Functional Laterality; Hallucinations; Humans; Levodopa; Male; Nerve Net; Neuropsychological Tests; Parkinson Disease; Sleep, REM	2008
Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients. Stereotactic and functional neurosurgery, 2009, Volume: 87, Issue:1 Topics: Aged; Antiparkinson Agents; Deep Brain Stimulation; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome	2009
Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, May-15, Volume: 24, Issue:7 Topics: Aged; Antiparkinson Agents; Dementia; Duodenum; Female; Gait Disorders, Neurologic; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Personal Autonomy; Quality of Life; Retrospective Studies; Treatment Outcome	2009
Parkinsonism, dysautonomia, REM behaviour disorder and visual hallucinations mimicking synucleinopathy in a patient with progressive supranuclear palsy. Journal of neurology, neurosurgery, and psychiatry, 2009, Volume: 80, Issue:5 Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Brain; Fatal Outcome; Female; Hallucinations; Humans; Levodopa; Middle Aged; Parkinson Disease; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive; Synucleins; tau Proteins	2009
Clinical features associated with REM sleep behavior disorder symptoms in the early stages of Parkinson's disease. Journal of neurology, 2011, Volume: 258, Issue:1 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Disease Progression; Female; Hallucinations; Humans; Levodopa; Male; Movement; Parkinson Disease; Polysomnography; Prognosis; REM Sleep Behavior Disorder; Surveys and Questionnaires; Tremor	2011
Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease. Parkinsonism & related disorders, 2011, Volume: 17, Issue:1 Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Deoxyguanosine; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Neuropsychological Tests; Oxidative Stress; Parkinson Disease; Reference Values	2011
Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions. Journal of neurosurgery, 2011, Volume: 114, Issue:6 Topics: Adult; Aged; Antiparkinson Agents; Deep Brain Stimulation; Delusions; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome	2011
Feeling of presence in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:11 Topics: Aged; Aged, 80 and over; Case-Control Studies; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Perceptual Disorders; Psychotic Disorders; Surveys and Questionnaires	2011
Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours. The International journal of neuroscience, 2011, Volume: 121, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Compulsive Behavior; Delusions; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales	2011
Parkinsonism with multiple cysts in the bilateral striata. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2011, Volume: 11, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Antipsychotic Agents; Brain Ischemia; Delirium; Delusions; Diagnosis, Differential; Dibenzothiazepines; Dominance, Cerebral; Drug Therapy, Combination; Encephalomalacia; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neostriatum; Neurologic Examination; Organophosphate Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced; Quetiapine Fumarate; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2011
Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Autoradiography; Brain; Female; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Receptor, Serotonin, 5-HT1A; Visual Pathways	2012
Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2012, Volume: 27, Issue:8 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cohort Studies; Color Perception; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Movement; Neurologic Examination; Parkinson Disease; Polysomnography; Psychomotor Performance; REM Sleep Behavior Disorder; Smell; Socioeconomic Factors	2012
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease. Scottish medical journal, 2012, Volume: 57, Issue:4 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors	2012
New medication recommended for Parkinson's disease. Report on medical guidelines & outcomes research, 2001, Jun-28, Volume: 12, Issue:13 Topics: Clozapine; Dibenzothiazepines; Dopamine Agonists; Dyskinesias; Hallucinations; Humans; Levodopa; Parkinson Disease; Practice Guidelines as Topic; United States	2001
[Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation]. Nederlands tijdschrift voor geneeskunde, 2002, Aug-31, Volume: 146, Issue:35 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Drug Synergism; Drug Therapy, Combination; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors	2002
Clozapine withdrawal symptoms in a Parkinson's disease patient. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Aged; Antipsychotic Agents; Carbidopa; Clozapine; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Substance Withdrawal Syndrome	2002
[Hallucinations in Parkinson's disease]. Der Nervenarzt, 2003, Volume: 74, Issue:4 Topics: Antiparkinson Agents; Brain; Diagnosis, Differential; Dopamine Agonists; Hallucinations; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced; Risk Factors	2003
[Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis]. No to shinkei = Brain and nerve, 2003, Volume: 55, Issue:5 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cabergoline; Dibenzothiazepines; Ergolines; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate	2003
The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. Medical hypotheses, 2004, Volume: 62, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Hallucinations; Humans; Levodopa; Multiple Sclerosis; Oxidative Stress; Parkinson Disease; Parkinson Disease, Postencephalitic; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Vitamin B Complex	2004
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery]. No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:4 Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception	2004
Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism. Neurology, 2004, Jul-27, Volume: 63, Issue:2 Topics: Adult; Antiparkinson Agents; Basal Ganglia; Delirium; Epilepsy, Tonic-Clonic; Female; Hallucinations; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Levodopa; Lupus Erythematosus, Systemic; Parkinson Disease, Secondary; Prednisolone; Tomography, Emission-Computed, Single-Photon	2004
Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 2004, Volume: 111, Issue:10-11 Topics: Adult; Aged; Aged, 80 and over; Aging; Antiparkinson Agents; Dementia; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Risk Factors; United Kingdom	2004
Factors associated with drug-induced visual hallucinations in Parkinson's disease. Journal of neurology, 2005, Volume: 252, Issue:10 Topics: Age of Onset; Aged; Antiparkinson Agents; Female; Greece; Hallucinations; Humans; Interviews as Topic; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Prevalence; Psychoses, Substance-Induced; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Visual Acuity	2005
Association between family history of dementia and hallucinations in Parkinson disease. Neurology, 2005, May-24, Volume: 64, Issue:10 Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Cross-Sectional Studies; Dementia; DNA Mutational Analysis; Female; Genetic Testing; Hallucinations; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prevalence; Risk Factors; Surveys and Questionnaires; Ubiquitin-Protein Ligases	2005
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:2 Topics: Age Factors; Aged; Antiparkinson Agents; Cerebral Cortex; Drug Therapy, Combination; Female; Hallucinations; Humans; Interview, Psychological; Levodopa; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Risk Factors	2006
Low-dose levodopa therapy in Japanese patients with Parkinson's disease: a retrospective study. Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:9 Topics: Aged; Amantadine; Antiparkinson Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Hallucinations; Humans; Japan; Levodopa; Middle Aged; Parkinson Disease; Quality of Life; Retrospective Studies; Time Factors	2005
Hallucinations in Parkinson disease in the prelevodopa era. Neurology, 2006, Jan-10, Volume: 66, Issue:1 Topics: Affective Symptoms; Brain; Dementia; Dopamine; Dopamine Agents; Hallucinations; History, 19th Century; History, 20th Century; Humans; Levodopa; Neurology; Parkinson Disease; Psychotic Disorders	2006
Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. Journal of geriatric psychiatry and neurology, 2006, Volume: 19, Issue:1 Topics: Aged; Antiparkinson Agents; Female; Hallucinations; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Regression Analysis; Risk Factors; Statistics as Topic; Vision Tests; Visual Acuity	2006
Safety of rasagiline in elderly patients with Parkinson disease. Neurology, 2006, May-09, Volume: 66, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Confusion; Disorders of Excessive Somnolence; Dopamine Agonists; Double-Blind Method; Female; Hallucinations; Humans; Hypotension, Orthostatic; Incidence; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Randomized Controlled Trials as Topic	2006
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jan-30, Volume: 31, Issue:1 Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders	2007
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Grooming; Hallucinations; Levodopa; Parkinsonian Disorders; Psychomotor Agitation; Psychotic Disorders; Statistics, Nonparametric; Stereotyped Behavior	2006
Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. Journal of neurology, 2007, Volume: 254, Issue:4 Topics: Age of Onset; Aged; Aging; Antiparkinson Agents; Delusions; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Statistics, Nonparametric	2007
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain : a journal of neurology, 2007, Volume: 130, Issue:Pt 8 Topics: Accidental Falls; Adult; Age Factors; Age of Onset; Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Disease Progression; Female; Hallucinations; Humans; Levodopa; Lewy Bodies; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2007
Cerebral atrophy in Parkinson's disease patients with visual hallucinations. European journal of neurology, 2007, Volume: 14, Issue:7 Topics: Antiparkinson Agents; Antipsychotic Agents; Atrophy; Cerebral Cortex; Female; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parietal Lobe; Parkinson Disease; Severity of Illness Index; Temporal Lobe; Visual Cortex; Visual Pathways	2007
Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:10 Topics: Aged; Antiparkinson Agents; Comorbidity; Dementia; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; REM Sleep Behavior Disorder; Statistics as Topic	2007
The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-30, Volume: 23, Issue:6 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Australia; Dementia; Dyskinesias; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	2008
Difficulties in long term management of Parkinson's disease. Australian family physician, 1984, Volume: 13, Issue:5 Suppl Topics: Dementia; Depression; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa; Parkinson Disease; Time Factors	1984
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Carbidopa; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Pyridines	1984
Mental disorders in Parkinson's disease after treatment with L-DOPA. Advances in neurology, 1984, Volume: 40 Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1984
Psychiatric complications of levodopa therapy of Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Circadian Rhythm; Hallucinations; Humans; Hydrocortisone; Levodopa; Mental Disorders; Mood Disorders; Parkinson Disease; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Thinking	1984
Levodopa: long-term impact on Parkinson's disease. British medical journal (Clinical research ed.), 1981, Feb-07, Volume: 282, Issue:6262 Topics: Atrophy; Cerebral Cortex; Dementia; Hallucinations; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced	1981
Serotonergically active agents in levodopa-induced psychiatric toxicity reactions. Advances in neurology, 1983, Volume: 37 Topics: Amitriptyline; Hallucinations; Humans; Levodopa; Methysergide; Serotonin; Serotonin Antagonists; Sleep	1983
Complications of chronic levodopa therapy: long-term efficacy of drug holiday. Neurology, 1981, Volume: 31, Issue:4 Topics: Aged; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Substance Withdrawal Syndrome	1981
[A study on mental symptoms developing during the treatment of Parkinson's disease (author's transl)]. No to shinkei = Brain and nerve, 1980, Volume: 32, Issue:9 Topics: Aged; Amantadine; Delusions; Drug Therapy, Combination; Female; Hallucinations; Humans; Hypertension; Levodopa; Male; Middle Aged; Parkinson Disease	1980
The impact of treatment with levodopa on Parkinson's disease. The Quarterly journal of medicine, 1980, Volume: 49, Issue:195 Topics: Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1980
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients. Lancet (London, England), 1994, May-28, Volume: 343, Issue:8909 Topics: Aged; Antipsychotic Agents; Hallucinations; Humans; Isoxazoles; Levodopa; Parkinson Disease; Piperidines; Risperidone	1994
Adverse reactions to Sinemet CR. Journal of the American Geriatrics Society, 1995, Volume: 43, Issue:8 Topics: Aged; Antiparkinson Agents; Carbidopa; Confusion; Delayed-Action Preparations; Drug Combinations; Dyskinesia, Drug-Induced; Hallucinations; Humans; Levodopa	1995
Adverse reactions to controlled release levodopa/carbidopa in older persons: case reports. Journal of the American Geriatrics Society, 1995, Volume: 43, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Frail Elderly; Hallucinations; Humans; Levodopa; Male; Mental Status Schedule; Parkinson Disease; Severity of Illness Index	1995
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease. The American journal of psychiatry, 1993, Volume: 150, Issue:11 Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception	1993
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Annals of neurology, 1993, Volume: 34, Issue:5 Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM	1993
Therapeutic effect of clozapine in psychotic decompensation in idiopathic Parkinson's disease. Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:2 Topics: Aged; Benserazide; Blood Cell Count; Clozapine; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Paranoid Disorders; Parkinson Disease; Psychotic Disorders	1993
The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology, 1993, Volume: 43, Issue:8 Topics: Aged; Depression; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Restless Legs Syndrome; Urinary Incontinence	1993
Triphasic waves in serotonin syndrome. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:2 Topics: 1-Naphthylamine; Aged; Amantadine; Antiparkinson Agents; Brain Diseases; Carbidopa; Drug Combinations; Drug Therapy, Combination; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Syndrome	1997
Cenesthetic hallucinations in a patient with Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:1 Topics: Aged; Clozapine; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide	1997
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology, 1998, Volume: 50, Issue:2 Topics: Aged; Antiparkinson Agents; Drug Administration Schedule; Female; Hallucinations; Humans; Infusions, Intravenous; Levodopa; Male; Parkinson Disease; Time Factors	1998
Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:4 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Biomarkers; Catecholamines; Female; Hallucinations; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Isoquinolines; Levodopa; Male; Parkinson Disease; Reference Values; Regression Analysis; Tyrosine	1996
Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology, 1998, Volume: 51, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1998
Intravenous levodopa in hallucinating PD patients. Neurology, 1999, Jan-01, Volume: 52, Issue:1 Topics: Antiparkinson Agents; Hallucinations; Humans; Injections, Intravenous; Levodopa; Parkinson Disease	1999
Medication-induced hallucination and cerebral blood flow in Parkinson's disease. Journal of neurology, 1999, Volume: 246, Issue:5 Topics: Aged; Antiparkinson Agents; Cerebrovascular Circulation; Female; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Tomography, Emission-Computed, Single-Photon	1999
Deterioration of parkinsonian symptoms following treatment of dopaminergic hallucinosis with olanzapine. European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:6 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Male; Olanzapine; Paranoid Disorders; Parkinson Disease; Piperidines; Pirenzepine; Selegiline; Severity of Illness Index	1999
Ropinirole as compared with levodopa in Parkinson's disease. The New England journal of medicine, 2000, Sep-21, Volume: 343, Issue:12 Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Hallucinations; Humans; Indoles; Levodopa; Parkinson Disease	2000
Prospective longitudinal assessment of hallucinations in Parkinson's disease. Neurology, 2001, Dec-11, Volume: 57, Issue:11 Topics: Aged; Dementia; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Risk Factors	2001
[Hallucinations caused by paroxetine taken together with a levodopa-carbidopa preparation]. Nederlands tijdschrift voor geneeskunde, 2002, Mar-23, Volume: 146, Issue:12 Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Interactions; Drug Therapy, Combination; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors	2002
[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey]. Revue neurologique, 2002, Volume: 158, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Delusions; Female; France; Hallucinations; Health Surveys; Humans; Inpatients; Levodopa; Male; Middle Aged; Outpatients; Paranoid Disorders; Parkinson Disease; Severity of Illness Index; Sleep Wake Disorders	2002
[Hallucinations caused by paroxetine in combined usage of levodopa-carbidopa]. Nederlands tijdschrift voor geneeskunde, 2002, Jun-01, Volume: 146, Issue:22 Topics: Antidepressive Agents, Second-Generation; Antiparkinson Agents; Carbidopa; Drug Interactions; Hallucinations; Levodopa; Parkinson Disease; Paroxetine	2002
Dream phenomena induced by chronic levodopa therapy. Journal of neural transmission, 1978, Volume: 43, Issue:2 Topics: Adult; Aged; Carbidopa; Delusions; Dreams; Female; Hallucinations; Humans; Illusions; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1978
Visual hallucinations and delirium during treatment with amantadine (Symmetrel). Journal of the American Geriatrics Society, 1975, Volume: 23, Issue:5 Topics: Aged; Amantadine; Benztropine; Biperiden; Delirium; Drug Eruptions; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease	1975
Levodopa-induced psychosis: a kindling phenomenon. The American journal of psychiatry, 1978, Volume: 135, Issue:6 Topics: Adult; Aged; Chronic Disease; Confusion; Corpus Striatum; Delusions; Dreams; Female; Hallucinations; Humans; Levodopa; Limbic System; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine; Stimulation, Chemical; Time Factors	1978
Bromocriptine in parkinsonism. A long-term study. Archives of neurology, 1978, Volume: 35, Issue:8 Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System	1978
Nonconfusional paranoid psychosis secondary to anticholinergics? The American journal of psychiatry, 1978, Volume: 135, Issue:12 Topics: Hallucinations; Humans; Levodopa; Paranoid Disorders; Parasympatholytics	1978
L-tryptophan administration in L-dopa-induced hallucinations in elderly Parkinsonian patients. Gerontology, 1977, Volume: 23, Issue:6 Topics: Aged; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tryptophan	1977
Off-period screaming accompanying motor fluctuations in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:1 Topics: Antiparkinson Agents; Carbidopa; Crying; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Middle Aged; Parkinson Disease; Receptors, Dopamine	1991
Adrenal medulla autograft in 3 parkinsonian patients: results using two different approaches. Progress in brain research, 1990, Volume: 82 Topics: Adrenal Medulla; Caudate Nucleus; Combined Modality Therapy; Evaluation Studies as Topic; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Stereotaxic Techniques; Transplantation, Autologous; Transplantation, Heterotopic	1990
Clozapine for psychosis in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:3 Topics: Aged; Clozapine; Dibenzazepines; Dose-Response Relationship, Drug; Hallucinations; Humans; Levodopa; Male; Parkinson Disease	1990
Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1989
The prevalence and aetiology of long-term L-dopa side-effects in elderly parkinsonian patients. Age and ageing, 1989, Volume: 18, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Female; Hallucinations; Humans; Hypotension, Orthostatic; Levodopa; Male; Movement Disorders; Parkinson Disease; Scotland; Time Factors	1989
Acute postoperative confusion and hallucinations in Parkinson disease. Annals of internal medicine, 1989, Aug-01, Volume: 111, Issue:3 Topics: Aged; Aged, 80 and over; Carbidopa; Cognition Disorders; Confusion; Drug Combinations; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Retrospective Studies; Risk	1989
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine. European archives of psychiatry and neurological sciences, 1985, Volume: 235, Issue:1 Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan	1985
Parkinsonism: candidate disorder for implanted pumps? Annals of the New York Academy of Sciences, 1988, Volume: 531 Topics: Antiparkinson Agents; Brain; Corpus Striatum; Dopamine; Hallucinations; Humans; Infusion Pumps; Levodopa; Neurotransmitter Agents; Parkinson Disease; Receptors, Dopamine	1988
[Psychiatric symptoms and plasma levodopa dynamics in Parkinson's disease]. Rinsho shinkeigaku = Clinical neurology, 1987, Volume: 27, Issue:7 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Dopamine; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease	1987
Behavioral indicators of hallucinosis in levodopa-treated Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Hallucinations; Humans; Levodopa; Middle Aged; MMPI; Parkinson Disease; Psychometrics; Risk	1987
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology, 1985, Volume: 35, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors	1985
[L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1974, Volume: 74, Issue:5 Topics: Cardiovascular Diseases; Dyspepsia; Fear; Hallucinations; Humans; Hyperkinesis; Levodopa; Mental Disorders; Nausea; Parkinson Disease; Postoperative Care; Preoperative Care; Vomiting	1974